-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Heron Therapeutics, Inc. /De/ annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
- Heron Therapeutics, Inc. /De/ Operating Lease, Payments for the quarter ending September 30, 2020 was $1M, a 25% increase year-over-year.
- Heron Therapeutics, Inc. /De/ Operating Lease, Payments for the twelve months ending September 30, 2020 was $3.3M.
- Heron Therapeutics, Inc. /De/ annual Operating Lease, Payments for 2023 was $3M, a 3.45% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Operating Lease, Payments for 2022 was $2.9M.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)